Novo Nordisk A/S (NVO) Stock: Charts & Financials

Novo Nordisk A/S (NVO)NVONovo Nordisk A/S

About Novo Nordisk A/S

Novo Nordisk A/S is a global pharmaceutical firm dedicated to the investigation, creation, manufacturing, and distribution of medicinal products across a vast international footprint. Its market presence extends throughout Europe, the Middle East, Africa, various parts of Asia (including Mainland China, Hong Kong, and Taiwan), and North America. The company's operations are structured into two principal business units: Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity Care division delivers therapies for diabetes, obesity, cardiovascular ailments, and other emerging therapeutic areas. Meanwhile, the Rare Disease division concentrates on providing treatments for rare blood disorders, uncommon endocrine conditions, and hormone replacement solutions. In addition to its core pharmaceutical offerings, Novo Nordisk produces specialized medical equipment such as insulin pens, growth hormone pens, and injection needles. It also pioneers smart digital solutions for diabetes management, including advanced insulin pens and the Dose Check application, designed to guide insulin dosage. The company engages in strategic alliances, notably a partnership with UNICEF to combat childhood obesity and a collaboration with Valo Health, Inc. to discover and advance novel drug pipelines in the cardiometabolic space. Founded in 1923, Novo Nordisk A/S is headquartered in Bagsvaerd, Denmark.

Bagsvaerd, CR

77,406 employees

www.novonordisk.com

Healthcare / Drug Manufacturers - General

Sector: Healthcare
Industry: Drug Manufacturers - General
CEO: Maziar Mike Doustdar

View full financials

Quarterly Report	TTM	Quarter ended Mar 2026	Quarter ended Dec 2025	Quarter ended Sep 2025	Quarter ended Jun 2025	Quarter ended Mar 2025	Quarter ended Dec 2024	Quarter ended Sep 2024	Quarter ended Jun 2024
Total Current Assets	27.34B	27.34B	27.06B	28.52B	25.63B	25.27B	22.27B	29.12B	3.67B
Cash & Cash Equivalents	3.26B	3.26B	4.15B	5.03B	2.90B	5.64B	2.17B	8.51B	1.09B
Short-Term Investments	76.95M	76.95M	78.14M	78.24M	78.61M	378.48M	1.47B	2.67B	203.48M
Cash & Short-Term Investments	3.33B	3.33B	4.23B	5.11B	2.98B	6.02B	3.64B	11.17B	1.30B
Accounts Receivable	15.46B	15.46B	11.88B	14.48B	13.52B	12.51B	12.10B	10.37B	1.38B
Inventory	7.92B	7.92B	7.79B	7.45B	7.19B	6.21B	5.65B	5.66B	752.34M
Total Assets	86.23B	86.23B	85.18B	80.33B	75.95B	70.88B	64.47B	59.31B	7.64B
Property, Plant & Equipment	33.92B	33.92B	32.69B	30.30B	28.47B	24.98B	22.49B	17.88B	2.28B
Goodwill	3.07B	3.07B	3.11B	0.00	0.00	0.00	2.78B	0.00	0.00
Intangible Assets	16.97B	16.97B	17.29B	16.71B	16.99B	15.85B	12.60B	8.13B	1.15B
Long-Term Investments	345.56M	345.56M	393.35M	427.28M	415.56M	391.23M	370.50M	305.47M	34.33M
Total Current Liabilities	34.72B	34.72B	33.84B	36.75B	32.69B	34.21B	30.11B	31.09B	3.89B
Accounts Payable	20.67B	20.67B	3.10B	3.75B	4.44B	2.84B	3.99B	3.59B	615.82M
Short-Term Debt	4.20B	4.20B	1.89B	1.89B	1.88B	3.25B	1.63B	823.75M	112.82M
Total Liabilities	54.92B	54.92B	54.74B	53.69B	49.48B	50.81B	44.61B	41.32B	5.32B
Long-Term Debt	18.38B	18.38B	17.32B	13.98B	13.75B	13.96B	11.66B	7.68B	1.07B
Total Debt	22.57B	22.57B	20.55B	15.87B	15.64B	17.20B	14.23B	8.50B	1.18B
Net Debt (Cash)	19.31B	19.31B	16.40B	10.84B	12.73B	11.56B	12.06B	-6.86M	87.72M
Total Shareholders' Equity	31.31B	31.31B	30.45B	26.64B	26.48B	20.07B	19.86B	17.99B	2.33B
Common Stock	68.77M	68.77M	69.98M	69.93M	70.26M	64.63M	61.73M	66.56M	9.23M
Retained Earnings	31.83B	31.83B	30.64B	26.43B	25.91B	19.90B	19.99B	18.16B	2.32B
Current Ratio	0.79	0.79	0.80	0.78	0.78	0.74	0.74	0.94	0.94
Debt to Equity Ratio	0.72	0.72	0.67	0.60	0.59	0.86	0.72	0.47	0.51

Quarterly Report

TTM

Quarter ended Mar 2026

Quarter ended Dec 2025

Quarter ended Sep 2025

Quarter ended Jun 2025

Quarter ended Mar 2025

Quarter ended Dec 2024

Quarter ended Sep 2024

Quarter ended Jun 2024

Total Current Assets

27.34B

27.06B

28.52B

25.63B

25.27B

22.27B

29.12B

3.67B

Cash & Cash Equivalents

3.26B

4.15B

5.03B

2.90B

5.64B

2.17B

8.51B

1.09B

Short-Term Investments

76.95M

78.14M

78.24M

78.61M

378.48M

1.47B

2.67B

203.48M

Cash & Short-Term Investments

3.33B

4.23B

5.11B

2.98B

6.02B

3.64B

11.17B

1.30B

Accounts Receivable

15.46B

11.88B

14.48B

13.52B

12.51B

12.10B

10.37B

1.38B

Inventory

7.92B

7.79B

7.45B

7.19B

6.21B

5.65B

5.66B

752.34M

Total Assets

86.23B

85.18B

80.33B

75.95B

70.88B

64.47B

59.31B

7.64B

Property, Plant & Equipment

33.92B

32.69B

30.30B

28.47B

24.98B

22.49B

17.88B

2.28B

Goodwill

3.07B

3.11B

0.00

2.78B

0.00

Intangible Assets

16.97B

17.29B

16.71B

16.99B

15.85B

12.60B

8.13B

1.15B

Long-Term Investments

345.56M

393.35M

427.28M

415.56M

391.23M

370.50M

305.47M

34.33M

Total Current Liabilities

34.72B

33.84B

36.75B

32.69B

34.21B

30.11B

31.09B

3.89B

Accounts Payable

20.67B

3.10B

3.75B

4.44B

2.84B

3.99B

3.59B

615.82M

Short-Term Debt

4.20B

1.89B

1.88B

3.25B

1.63B

823.75M

112.82M

Total Liabilities

54.92B

54.74B

53.69B

49.48B

50.81B

44.61B

41.32B

5.32B

Long-Term Debt

18.38B

17.32B

13.98B

13.75B

13.96B

11.66B

7.68B

1.07B

Total Debt

22.57B

20.55B

15.87B

15.64B

17.20B

14.23B

8.50B

1.18B

Net Debt (Cash)

19.31B

16.40B

10.84B

12.73B

11.56B

12.06B

-6.86M

87.72M

Total Shareholders' Equity

31.31B

30.45B

26.64B

26.48B

20.07B

19.86B

17.99B

2.33B

Common Stock

68.77M

69.98M

69.93M

70.26M

64.63M

61.73M

66.56M

9.23M

Retained Earnings

31.83B

30.64B

26.43B

25.91B

19.90B

19.99B

18.16B

2.32B

Current Ratio

0.79

0.80

0.78

0.74

0.94

Debt to Equity Ratio

0.72

0.67

0.60

0.59

0.86

0.72

0.47

0.51

Annual Report	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018
Total Current Assets	27.06B	22.27B	20.67B	15.53B	13.08B	1.77B	1.40B	9.07B
Cash & Cash Equivalents	4.15B	2.17B	2.13B	1.82B	1.64B	343.49M	348.00M	2.40B
Short-Term Investments	78.14M	1.47B	2.34B	1.57B	1.03B	0.00	0.00	0.00
Cash & Short-Term Investments	4.23B	3.64B	4.47B	3.38B	2.67B	343.49M	348.00M	2.40B
Accounts Receivable	11.88B	12.10B	11.14B	8.25B	7.15B	754.53M	578.34M	4.13B
Inventory	7.79B	5.65B	4.71B	3.50B	3.00B	499.09M	396.70M	2.51B
Total Assets	85.18B	64.47B	46.55B	34.62B	29.73B	3.90B	2.82B	17.01B
Property, Plant & Equipment	32.69B	22.49B	13.46B	9.57B	8.46B	1.35B	1.14B	6.43B
Goodwill	3.11B	2.78B	660.76M	730.70M	664.24M	0.00	0.00	0.00
Intangible Assets	17.29B	12.60B	8.28B	6.65B	5.93B	556.20M	131.22M	790.27M
Long-Term Investments	393.35M	370.50M	246.16M	192.72M	220.24M	44.37M	40.66M	272.33M
Total Current Liabilities	33.84B	30.11B	25.11B	17.35B	15.21B	1.89B	1.33B	8.32B
Accounts Payable	3.10B	3.99B	3.79B	2.24B	1.36B	153.93M	142.98M	1.04B
Short-Term Debt	1.89B	1.63B	785.10M	68.88M	1.97B	200.84M	33.15M	79.10M
Total Liabilities	54.74B	44.61B	30.78B	22.64B	18.92B	2.20B	1.53B	9.05B
Long-Term Debt	17.32B	11.66B	2.36B	2.98B	1.48B	0.00	0.00	0.00
Total Debt	20.55B	14.23B	4.00B	3.70B	4.07B	278.84M	100.81M	79.10M
Net Debt (Cash)	16.40B	12.06B	1.87B	1.88B	2.43B	-64.65M	-247.18M	-2.32B
Total Shareholders' Equity	30.45B	19.86B	15.77B	11.98B	10.81B	1.71B	1.30B	7.96B
Common Stock	69.98M	61.73M	66.76M	65.44M	70.61M	12.65M	10.79M	75.26M
Retained Earnings	30.64B	19.99B	15.52B	11.56B	11.01B	1.72B	1.30B	8.20B
Current Ratio	0.80	0.74	0.82	0.89	0.86	0.94	1.06	1.09
Debt to Equity Ratio	0.67	0.72	0.25	0.31	0.38	0.16	0.08	0.01

Annual Report

12/31/2025

12/31/2024

12/31/2023

12/31/2022

12/31/2021

12/31/2020

12/31/2019

12/31/2018

Total Current Assets

27.06B

22.27B

20.67B

15.53B

13.08B

1.77B

1.40B

9.07B

Cash & Cash Equivalents

4.15B

2.17B

2.13B

1.82B

1.64B

343.49M

348.00M

2.40B

Short-Term Investments

78.14M

1.47B

2.34B

1.57B

1.03B

0.00

Cash & Short-Term Investments

4.23B

3.64B

4.47B

3.38B

2.67B

343.49M

348.00M

2.40B

Accounts Receivable

11.88B

12.10B

11.14B

8.25B

7.15B

754.53M

578.34M

4.13B

Inventory

7.79B

5.65B

4.71B

3.50B

3.00B

499.09M

396.70M

2.51B

Total Assets

85.18B

64.47B

46.55B

34.62B

29.73B

3.90B

2.82B

17.01B

Property, Plant & Equipment

32.69B

22.49B

13.46B

9.57B

8.46B

1.35B

1.14B

6.43B

Goodwill

3.11B

2.78B

660.76M

730.70M

664.24M

0.00

Intangible Assets

17.29B

12.60B

8.28B

6.65B

5.93B

556.20M

131.22M

790.27M

Long-Term Investments

393.35M

370.50M

246.16M

192.72M

220.24M

44.37M

40.66M

272.33M

Total Current Liabilities

33.84B

30.11B

25.11B

17.35B

15.21B

1.89B

1.33B

8.32B

Accounts Payable

3.10B

3.99B

3.79B

2.24B

1.36B

153.93M

142.98M

1.04B

Short-Term Debt

1.89B

1.63B

785.10M

68.88M

1.97B

200.84M

33.15M

79.10M

Total Liabilities

54.74B

44.61B

30.78B

22.64B

18.92B

2.20B

1.53B

9.05B

Long-Term Debt

17.32B

11.66B

2.36B

2.98B

1.48B

0.00

Total Debt

20.55B

14.23B

4.00B

3.70B

4.07B

278.84M

100.81M

79.10M

Net Debt (Cash)

16.40B

12.06B

1.87B

1.88B

2.43B

-64.65M

-247.18M

-2.32B

Total Shareholders' Equity

30.45B

19.86B

15.77B

11.98B

10.81B

1.71B

1.30B

7.96B

Common Stock

69.98M

61.73M

66.76M

65.44M

70.61M

12.65M

10.79M

75.26M

Retained Earnings

30.64B

19.99B

15.52B

11.56B

11.01B

1.72B

1.30B

8.20B

Current Ratio

0.80

0.74

0.82

0.89

0.86

0.94

1.06

1.09

Debt to Equity Ratio

0.67

0.72

0.25

0.31

0.38

0.16

0.08

0.01

Balance Sheet

Quarterly Balance Sheet (USD)

Annual Balance Sheet (USD)